| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |